Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cipla
Argus Health
Harvard Business School
US Department of Justice
US Army
Daiichi Sankyo
Medtronic
Boehringer Ingelheim
Federal Trade Commission

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019508

« Back to Dashboard

NDA 019508 describes AXID, which is a drug marketed by Smithkline Beecham, Braintree, and Pfizer, and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the AXID profile page.

The generic ingredient in AXID is nizatidine. There are seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Summary for 019508
Tradename:AXID
Applicant:Smithkline Beecham
Ingredient:nizatidine
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019508

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength150MG
Approval Date:Apr 12, 1988TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength300MG
Approval Date:Apr 12, 1988TE:RLD:No

Expired US Patents for NDA 019508

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
US Army
Johnson and Johnson
Colorcon
McKinsey
Mallinckrodt
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot